Transport of drugs in the kidney by the human organic cation transporter, OCT2 and its genetic variants

被引:92
作者
Fujita, T [1 ]
Urban, TJ [1 ]
Leabman, MK [1 ]
Fujita, K [1 ]
Giacomini, KM [1 ]
机构
[1] Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA
关键词
organic cation transporter; pharmacokinetics; kidney transporters; metformin; pharmacogenetics;
D O I
10.1002/jps.20536
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The human organic cation transporter 2 (OCT2, SLC22A2) is a multispecific transporter of organic cations, including many clinically used drugs. OCT2 is primarily responsible for the uptake of organic cations across the basolateral membrane of renal tubular epithelial cells and is considered a major transporter in the active secretion of organic cations in the kidney. Uptake of organic cations by OCT2 is driven by the inside-negative membrane potential and is pH-sensitive. Regulation of OCT2 at the transcriptional level by steroid hormones and at the protein level by various protein kinases has been described. Several human genetic variants in the coding region of OCT2 have been identified and functionally characterized, including both polymorphic and rare variants. A variety of structurally diverse compounds have been shown to interact with OCT2, including endogenous compounds, drugs, and dietary supplements. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:25 / 36
页数:12
相关论文
共 37 条
[1]   The human organic cation transporter (hOCT2) recognizes the degree of substrate ionization [J].
Barendt, WM ;
Wright, SH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (25) :22491-22496
[2]   The role of multidrug, transporters in drug availability, metabolism and toxicity [J].
Bodó, A ;
Bakos, E ;
Szeri, F ;
Váradi, A ;
Sarkadi, B .
TOXICOLOGY LETTERS, 2003, 140 :133-143
[3]   Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine [J].
Busch, AE ;
Karbach, U ;
Miska, D ;
Gorboulev, V ;
Akhoundova, A ;
Volk, C ;
Arndt, P ;
Ulzheimer, JC ;
Sonders, MS ;
Baumann, C ;
Waldegger, S ;
Lang, F ;
Koepsell, H .
MOLECULAR PHARMACOLOGY, 1998, 54 (02) :342-352
[4]   Regulation of human organic cation transporter hOCT2 by PKA, PI3K, and calmodulin-dependent kinases [J].
Çetinkaya, I ;
Ciarimboli, G ;
Yalçinkaya, G ;
Mehrens, T ;
Velic, A ;
Hirsch, JR ;
Gorboulev, V ;
Koepsell, H ;
Schlatter, E .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2003, 284 (02) :F293-F302
[5]   Utility of mdr1-gene deficient mice in assessing the impact of P-glycoprotein on pharmacokinetics and pharmacodynamics in drug discovery and development [J].
Chen, CP ;
Liu, XR ;
Smith, BJ .
CURRENT DRUG METABOLISM, 2003, 4 (04) :272-291
[6]   Interactions of n-tetraalkylammonium compounds and biguanides with a human renal organic cation transporter (hOCT2) [J].
Dresser, MJ ;
Xiao, GQ ;
Leabman, MK ;
Gray, AT ;
Giacomini, KM .
PHARMACEUTICAL RESEARCH, 2002, 19 (08) :1244-1247
[7]  
Fujita Tomoe, 2005, Pharmacogenet Genomics, V15, P201, DOI 10.1097/01213011-200504000-00003
[8]  
Fukushima-Uesaka Hiromi, 2004, Drug Metab Pharmacokinet, V19, P239, DOI 10.2133/dmpk.19.239
[9]   Cloning and characterization of two human polyspecific organic cation transporters [J].
Gorboulev, V ;
Ulzheimer, JC ;
Akhoundova, A ;
UlzheimerTeuber, I ;
Karbach, U ;
Quester, S ;
Baumann, C ;
Lang, F ;
Busch, AE ;
Koepsell, H .
DNA AND CELL BIOLOGY, 1997, 16 (07) :871-881
[10]   Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3 [J].
Hayer-Zillgen, M ;
Brüss, M ;
Bönisch, H .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 136 (06) :829-836